BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30192158)

  • 1. Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway.
    Zhang M; Ding G; Zhou L; Shen T; Xu X; Zhao T; Jia S; Cao L
    J Interferon Cytokine Res; 2018 Sep; 38(9):413-422. PubMed ID: 30192158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.
    Yi B; Hu Y; Qin G; Gu W; Zhu X; He S; Zhou J; Li D
    Int J Mol Med; 2014 Jul; 34(1):205-12. PubMed ID: 24788627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoGDI2 is expressed in human trophoblasts and involved in their migration by inhibiting the activation of RAC1.
    Liu S; Cui H; Li Q; Zhang L; Na Q; Liu C
    Biol Reprod; 2014 Apr; 90(4):88. PubMed ID: 24554735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.
    Zheng QY; Cao ZH; Hu XB; Li GQ; Dong SF; Xu GL; Zhang KQ
    J Cell Mol Med; 2016 Oct; 20(10):1861-71. PubMed ID: 27241100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
    Cao L; Liu J; Zhang L; Xiao X; Li W
    Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 is involved in IFN-γ- and TNF-α-mediated MIN6 cells apoptosis via NF-κB/Bcl-2 pathway.
    Cao ZH; Yin WD; Zheng QY; Feng SL; Xu GL; Zhang KQ
    Cell Biochem Biophys; 2013; 67(3):1239-48. PubMed ID: 23695786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma.
    Yi B; Zhang Y; Zhu D; Zhang L; Song S; He S; Zhang B; Li D; Zhou J
    Oncol Rep; 2015 Mar; 33(3):1201-6. PubMed ID: 25573518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
    Griner EM; Dancik GM; Costello JC; Owens C; Guin S; Edwards MG; Brautigan DL; Theodorescu D
    Mol Cancer Res; 2015 Mar; 13(3):483-92. PubMed ID: 25516960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of phospho-p85α-GTP-Rac1 lipid raft interaction by bichalcone analog attenuates cancer cell invasion.
    Lu HL; Chen SS; Hsu WT; Lu YC; Lee CC; Wu TS; Lin ML
    Mol Carcinog; 2016 Dec; 55(12):2106-2120. PubMed ID: 26756739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.
    Li L; Aggarwal BB; Shishodia S; Abbruzzese J; Kurzrock R
    Cancer; 2004 Nov; 101(10):2351-62. PubMed ID: 15476283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression.
    Xia B; Wang J
    Drug Des Devel Ther; 2019; 13():3837-3844. PubMed ID: 32109988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma.
    Gastonguay A; Berg T; Hauser AD; Schuld N; Lorimer E; Williams CL
    Cancer Biol Ther; 2012 Jun; 13(8):647-56. PubMed ID: 22549160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
    Johnson JL; de Mejia EG
    Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of the NF-κB-JNK pathway is independent of the PI3K-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration.
    Xuan Y; Chi L; Tian H; Cai W; Sun C; Wang T; Zhou X; Shao M; Zhu Y; Niu C; Sun Y; Cong W; Zhu Z; Li Z; Wang Y; Jin L
    J Dermatol Sci; 2016 Apr; 82(1):28-37. PubMed ID: 26829882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
    Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
    Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Src mediates thrombin-induced NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells.
    Lin CH; Cheng HW; Hsu MJ; Chen MC; Lin CC; Chen BC
    J Immunol; 2006 Sep; 177(5):3427-38. PubMed ID: 16920985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
    Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
    Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.